Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Bahar Dakiki"'
Autor:
Birol Ocak, Ahmet Bilgehan Sahin, Ismail Ertürk, Mustafa Korkmaz, Dilek Erdem, Umut Cakıroglu, Mustafa Karaca, Ahmet Dirican, Omer Fatih Olmez, Sabin Goktas Aydın, Ali Gökyer, Ahmet Kücükarda, Ahmet Gülmez, Perran Fulden Yumuk, Nazim Can Demircan, Abdilkerim Oyman, Teoman Sakalar, Fatih Karatas, Hacer Demir, Ayse Irem Yasin, Adem Deligonul, Bahar Dakiki, Mehmet Refik Goktug, Okan Avcı, Seher Yildiz Tacar, Nazım Serdar Turhal, Gülhan Ipek Deniz, Turgut Kacan, Erdem Cubukcu, Türkkan Evrensel
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5195-5205 (2024)
Background: This study aimed to investigate the effect of cytoreductive nephrectomy (CN) on the survival outcomes of nivolumab used as a subsequent therapy after the failure of at least one anti-vascular endothelial growth factor (VEGF) agent in pati
Externí odkaz:
https://doaj.org/article/e3b91b5047204acf948136cd657f8dec
Autor:
Birol Ocak, Fatma Öz Atalay, Ahmet Bilgehan Sahin, Mine Ozsen, Bahar Dakiki, Seray Türe, Merve Mesohorli, Hikmet Utku Odman, Özgür Tanrıverdi, Gökhan Ocakoğlu, Mehmet Bayrak, Hakan Ozan, Candan Demiröz, Seda Sali, Sibel Oyucu Orhan, Adem Deligönül, Erdem Cubukcu, Türkkan Evrensel
Publikováno v:
Biomolecules & Biomedicine, Vol 21, Iss 5 (2021)
Endometrial endometrioid carcinoma (EEC) represents approximately 75-80% of endometrial carcinoma cases. Three hundred and thirty-six patients with EEC followed-up in the authors’ medical center between 2010 and 2018 were included in our study. Two
Externí odkaz:
https://doaj.org/article/db46d62a731e4306b405413e32d48f98
Autor:
Birol OCAK, Ahmet Bilgehan ŞAHİN, Candan DEMİRÖZ ABAKAY, Seda SALİ, Bahar DAKİKİ, Gizem İŞLEK, Burcu CANER, Kemal ÖZERKAN, Adem DELİGÖNÜL, Erdem ÇUBUKÇU, Türkkan EVRENSEL
Publikováno v:
Volume: 48, Issue: 1 37-41
Uludağ Üniversitesi Tıp Fakültesi Dergisi
Uludağ Üniversitesi Tıp Fakültesi Dergisi
Endometrial cancer (EC) is the most common gynecological malignancy in developed countries. Obesity is known as the major risk factor for endometrial cancer. The most common subtype of endometrial cancer is endometrioid endometrial carcinoma (EEC). O
Autor:
Seda Sali, Erdem Cubukcu, Ozgur Tanriverdi, Bahar Dakiki, Fatma Öz Atalay, Candan Demiröz Abakay, Ahmet Z. Sahin, Mine Özşen, Hakan Ozan, Mehmet Bayrak, Turkkan Evrensel, Seray Ture, Birol Ocak, Adem Deligonul
Publikováno v:
Ginekologia Polska. 93:112-120
Objectives: Endometrial endometrioid carcinoma (EEC) is the most encountered subtype of endometrial cancer (EC). Our study aimed to investigate the factors affecting recurrence in patients with stage 1A and 1B EEC. Material and methods: Our study inc
Autor:
Birol Ocak, Ahmet Bilgehan Sahin, Ismail Ertürk, Mustafa Korkmaz, Dilek Erdem, Umut Cakıroglu, Mustafa Karaca, Ahmet Dirican, Omer Fatih Olmez, Sabin Göktaş Aydın, Ali Gökyer, Ahmet Küçükarda, Ahmet Gülmez, Perran Fulden Yumuk, Nazim Can Demircan, Abdilkerim Oyman, Teoman Sakalar, Fatih Karataş, Hacer Demir, Ayse Irem Yasin, Adem Deligönül, Bahar Dakiki, Mehmet Refik Goktug, Okan Avcı, Seher Yildiz Tacar, Nazım Serdar Turhal, Gulhan Ipek Deniz, Turgut Kacan, Erdem Cubukcu, Türkkan Evrensel
Renal cell carcinoma is the fourteenth most common cancer in the world with a male to female ratio of 2:1, and clear cell renal cell carcinoma (ccRCC) is the most common histological subtype. Nivolumab is preferred as subsequent therapy in patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e5a15870b5d76209b99a5b795b3e4bc
https://doi.org/10.21203/rs.3.rs-1693977/v1
https://doi.org/10.21203/rs.3.rs-1693977/v1
Autor:
İbrahim Ethem Pınar, Vildan Özkocaman, Fahir Özkalemkaş, Himmet Durgut, Bahar Dakiki, Tuba Ersal, Vildan Gürsoy, Cumali Yalçın, Bedrettin Orhan, Ömer Candar, Rıdvan Ali
Publikováno v:
Journal of clinical apheresisREFERENCES. 37(5)
Turkish Stem Cell Coordination Center (TURKOK) carries out the procurement process of unrelated allogeneic hematopoietic stem cells in Turkey. This study aims to compare the efficacy of both once-daily and divided-dose G-CSF administration and the or
Autor:
Birol OCAK, Süreyya SARIHAN, Ahmet Bilgehan ŞAHİN, Bahar DAKİKİ, Burcu CANER, Kemal GÜLŞEN, Özgür TANRIVERDİ, Adem DELİGÖNÜL, Erdem ÇUBUKÇU, Türkkan EVRENSEL
Publikováno v:
Supplement 1; Volume: 4, Issue: 71-80
Turkish Journal of Internal Medicine
Turkish Journal of Internal Medicine
Background: In non-small cell lung cancer (NSCLC), immunotherapy is a treatment option in patients without targetable mutations in second and later lines. Nevertheless, there is no validated test that can predict immunotherapy response.Material and M
Autor:
Birol Ocak, Adem Deligonul, Turkkan Evrensel, Hikmet Utku Odman, Ahmet Z. Sahin, Erdem Cubukcu, Bahar Dakiki
Publikováno v:
Uludağ Üniversitesi Tıp Fakültesi Dergisi. 46:25-29
ilişkilendirilmiştir. Malign peritoneal mezotelyoma (MPM) plevral tutulumdan sonra ikinci sıklıkta görülür. Çalışmamızda MPM tanısı alan hastalarda demografik özelliklerin, kullanılan tedavi seçeneklerinin incelenmesi amaçlandı. Ça
Autor:
Bahar Dakiki, Erdem Cubukcu, Sibel Oyucu Orhan, Ahmet Z. Sahin, Birol Ocak, Adem Deligonul, Turgut Kaçan, Hikmet Utku Odman, Turkkan Evrensel, Neslihan Hazel Saydam
Publikováno v:
Eurasian Journal of Medical Investigation.
Autor:
Birol Ocak, Ahmet Bilgehan Şahin, Bahar Dakiki, Hikmet Utku Odman, Sibel Oyucu Orhan, Adem Deligönül, Hüseyin Melek, Erdem Çubukçu, Türkkan Evrensel
Publikováno v:
Volume: 47, Issue: 4 770-778
Dicle Tıp Dergisi
Dicle Medical Journal, Vol 47, Iss 4, Pp 770-778 (2020)
Dicle Tıp Dergisi
Dicle Medical Journal, Vol 47, Iss 4, Pp 770-778 (2020)
Objective: Malignant mesothelioma is a rare and aggressive cancer. We aim to report our experience of stage 1 and 2 malign pleural mesothelioma (MPM) and investigate the prognostic factors. Methods: We retrospectively reviewed 37 patients with clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd89c15f2295f64819632e146faabbf
https://dergipark.org.tr/tr/pub/dicletip/issue/59037/850203
https://dergipark.org.tr/tr/pub/dicletip/issue/59037/850203